Clinical Trials Directory

Trials / Completed

CompletedNCT03888014

Intraoperative Fluorescence With Augmented Reality

Phase 4 Open Label Study Of Indocyanine Green Video Angiography (ICG-VA) And Comparative Utility Of Glow800 And FL800 Intraoperative ICG-VA Tools For Intracranial Lesions

Status
Completed
Phase
Study type
Observational
Enrollment
7 (actual)
Sponsor
Cedars-Sinai Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a study looking at a new way to evaluate vascular problems or tumors in brain surgery patients using a standard \& approved intravenous dye and augmented reality.

Detailed description

This is a study investigating a new technique with an approved medication (ICG or indocyanine green) and using that and a near infrared mode on a standard operating room microscope to see the information provided for vascular or neoplastic (tumor related) neurosurgical problems. The technique uses the data from the microscope and using ICG with augmented reality overlaying the data into the microscope view (this is the new process). The technique is called GLOW800.

Conditions

Interventions

TypeNameDescription
DEVICEGLOW800The treatment group will consist of patients who require a medically necessary craniotomy. If an investigator deems that it will be useful to see blood vessels better with indocyanine green (ICG) videoangiography (VA), patients may be consented for the use if ICG VA using augmented reality (GLOW800). This will not add additional time or risk to their surgery
DRUGindocyanine green (ICG)This is a standard medication which can be given IV during a surgery to better visualize blood vessels under the microscope

Timeline

Start date
2019-07-01
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2019-03-25
Last updated
2023-01-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03888014. Inclusion in this directory is not an endorsement.